{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:12:50Z","timestamp":1778634770204,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI116812"],"award-info":[{"award-number":["R01AI116812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127744"],"award-info":[{"award-number":["R01AI127744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG069226"],"award-info":[{"award-number":["R21AG069226"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54CA210181"],"award-info":[{"award-number":["U54CA210181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.trsl.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T21:18:11Z","timestamp":1654636691000},"page":"13-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine"],"prefix":"10.1016","volume":"249","author":[{"given":"Awadalkareem","family":"Adam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha R.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia V","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1511-0793","authenticated-orcid":false,"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2022.06.004_bib0001","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trsl.2022.06.004_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-021-00523-5","article-title":"SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.trsl.2022.06.004_bib0003","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.06.004_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2022.06.004_bib0007","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.06.004_bib0008","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and Immunogenicity of two RNA-based COVID-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2022.06.004_bib0009","article-title":"Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2022.06.004_bib0010","article-title":"Editorial: Revised World Health Organization (WHO) terminology for variants of concern and variants of interest of SARS-CoV-2","volume":"27","author":"Parums","year":"2021","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.trsl.2022.06.004_bib0011","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.chom.2021.02.020","article-title":"The variant gambit: COVID-19\u2032s next move","volume":"29","author":"Plante","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.trsl.2022.06.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2022.06.004_bib0013","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/08820139.2021.1936009","article-title":"SARS-CoV-2: unique challenges of the virus and vaccines","volume":"50","author":"Mahmoodpoor","year":"2021","journal-title":"Immunol Invest"},{"key":"10.1016\/j.trsl.2022.06.004_bib0014","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0016","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.celrep.2015.04.009","article-title":"Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response","volume":"11","author":"Xia","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2022.06.004_bib0017","article-title":"Synergistic activation of antitumor immunity by a particulate therapeutic vaccine","volume":"8","author":"Mai","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.trsl.2022.06.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001284","article-title":"Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge","volume":"19","author":"Muruato","year":"2021","journal-title":"PLoS Biol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0019","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2022.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2022.06.004_bib0021","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/JVI.02488-15","article-title":"Dysregulation of toll-like receptor 7 compromises innate and adaptive T cell responses and host resistance to an attenuated West Nile virus infection in old mice","volume":"90","author":"Xie","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0022","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1574-695X.2011.00840.x","article-title":"Vgamma4+ T cells regulate host immune response to West Nile virus infection","volume":"63","author":"Welte","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0023","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.4049\/jimmunol.1800892","article-title":"Multiplexed FluoroSpot for the analysis of dengue virus- and Zika virus-specific and cross-reactive memory B cells","volume":"201","author":"Adam","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0024","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1038\/s41467-020-17892-0","article-title":"A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation","volume":"11","author":"Muruato","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.06.004_bib0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmii.2015.05.007","article-title":"Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB\/c mice","volume":"50","author":"Rostamian","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.trsl.2022.06.004_bib0026","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.06.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1807836","article-title":"Immune responses during COVID-19 infection","volume":"9","author":"Melenotte","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.trsl.2022.06.004_bib0028","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jmii.2020.03.015","article-title":"Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection","volume":"53","author":"Lin","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.trsl.2022.06.004_bib0029","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41587-020-0659-0","article-title":"Evaluation of SARS-CoV-2 serology assays reveals a range of test performance","volume":"38","author":"Whitman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0031","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1086\/381535","article-title":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome","volume":"189","author":"Li","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trsl.2022.06.004_bib0032","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.trsl.2022.06.004_bib0033","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2022.06.004_bib0034","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.06.004_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coi.2012.03.008","article-title":"Adjuvants for human vaccines","volume":"24","author":"Alving","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2022.06.004_bib0036","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4161\/hv.22248","article-title":"Mini-chaperones: potential immuno-stimulators in vaccine design","volume":"9","author":"Bolhassani","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.trsl.2022.06.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103197","article-title":"Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice","volume":"63","author":"Worzner","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.trsl.2022.06.004_bib0038","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1038\/s41467-021-23942-y","article-title":"SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung","volume":"12","author":"Routhu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.06.004_bib0039","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-021-03530-2","article-title":"Adjuvanting a subunit COVID-19 vaccine to induce protective immunity","volume":"594","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.06.004_bib0040","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/smll.201201510","article-title":"Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy","volume":"9","author":"Xu","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.trsl.2022.06.004_bib0041","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1158\/1078-0432.CCR-12-2764","article-title":"Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery","volume":"19","author":"Shen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2022.06.004_bib0042","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.abg9857","article-title":"Scent of a vaccine","volume":"373","author":"Lund","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.trsl.2022.06.004_bib0043","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0044","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/j.vaccine.2010.03.032","article-title":"Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection","volume":"28","author":"Kim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2022.06.004_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"577","key":"10.1016\/j.trsl.2022.06.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.trsl.2022.06.004_bib0047","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/vaccines9050524","article-title":"Delivery Routes for COVID-19 Vaccines","volume":"9","author":"Park","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.trsl.2022.06.004_bib0048","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.vaccine.2021.03.006","article-title":"Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse","volume":"39","author":"Du","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.trsl.2022.06.004_bib0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","article-title":"Nanoparticle-based vaccines against respiratory viruses","volume":"10","author":"Al-Halifa","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2022.06.004_bib0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601556","article-title":"Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation","volume":"3","author":"Schneider","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.trsl.2022.06.004_bib0051","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.06.004_bib0052","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1002\/jmv.27239","article-title":"Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China","volume":"93","author":"Wu","year":"2021","journal-title":"J Med Virol."},{"key":"10.1016\/j.trsl.2022.06.004_bib0053","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMc2102017","article-title":"Neutralizing activity of BNT162b2-elicited serum","volume":"384","author":"Liu","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2022.06.004_bib0054","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-021-03693-y","article-title":"BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants","volume":"596","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.06.004_bib0055","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.trsl.2022.06.004_bib0056","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/08820139.2021.1936009","article-title":"SARS-CoV-2: unique challenges of the virus and vaccines","volume":"50","author":"Mahmoodpoor","year":"2021","journal-title":"Immunol Invest"},{"key":"10.1016\/j.trsl.2022.06.004_bib0057","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jama.2021.21921","article-title":"Immunogenicity of extended mRNA SARS-CoV-2 vaccine dosing intervals","volume":"327","author":"Grunau","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2022.06.004_bib0058","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2022.06.004_bib0059","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2022.06.004_bib0060","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41467-022-28544-w","article-title":"Neutralization against omicron SARS-CoV-2 from previous non-omicron infection","volume":"13","author":"Zou","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2022.06.004_bib0061","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41586-021-03673-2","article-title":"Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants","volume":"595","author":"Ku","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2022.06.004_bib0062","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a Golden Syrian Hamster Model: implications for disease pathogenesis and transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422001360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524422001360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:46:17Z","timestamp":1761828377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524422001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":62,"alternative-id":["S1931524422001360"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2022.06.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}